DEA schedule

Is oxcarbazepine a controlled substance?

Federal schedule for oxcarbazepine from the FDA NDC directory, checked against the DEA controlled substances list.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

No. Oxcarbazepine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and oxcarbazepine is not on the DEA controlled substances list.

Run it in Rivvi

Which 2027 plans near you dropped or restricted oxcarbazepine?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Oxcarbazepine
Source	What it lists
FDA NDC directory	129 prescription listings from 46 labelers, none with a DEA schedule
DEA controlled substances list	oxcarbazepine is not on the list

Oxcarbazepine NDC listings

NDC listings for Oxcarbazepine
NDC	Product	Form	Strength	Labeler	DEA schedule
17772-121	OXTELLAR XR	tablet	150 mg/1	Supernus Pharmaceuticals, Inc.	None
17772-122	OXTELLAR XR	tablet	300 mg/1	Supernus Pharmaceuticals, Inc.	None
17772-123	OXTELLAR XR	tablet	600 mg/1	Supernus Pharmaceuticals, Inc.	None
0078-0357	Trileptal	suspension	60 mg/mL	Novartis Pharmaceuticals Corporation	None
0078-0456	Trileptal	tablet, film coated	150 mg/1	Novartis Pharmaceuticals Corporation	None
0078-0337	Trileptal	tablet, film coated	300 mg/1	Novartis Pharmaceuticals Corporation	None
0078-0457	Trileptal	tablet, film coated	600 mg/1	Novartis Pharmaceuticals Corporation	None
33342-259	oxcarbazepine	for suspension	300 mg/5mL	Macleods Pharmaceuticals Limited	None
10135-798	Oxcarbazepine	suspension	300 mg/5mL	Marlex Pharmaceuticals, Inc	None
42806-600	Oxcarbazepine	suspension	300 mg/5mL	EPIC PHARMA, LLC	None
62135-841	Oxcarbazepine	suspension	300 mg/5mL	Chartwell RX, LLC	None
65162-649	Oxcarbazepine	suspension	300 mg/5mL	Amneal Pharmaceuticals LLC	None
68094-123	Oxcarbazepine	suspension	300 mg/5mL	Precision Dose, Inc.	None
68999-841	Oxcarbazepine	suspension	300 mg/5mL	Chartwell Governmental & Specialty RX, LLC.	None
69452-125	Oxcarbazepine	suspension	300 mg/5mL	Bionpharma Inc.	None
72162-2088	Oxcarbazepine	suspension	300 mg/5mL	Bryant Ranch Prepack	None
72162-2631	Oxcarbazepine	suspension	300 mg/5mL	Bryant Ranch Prepack	None
72205-354	OXCARBAZEPINE	suspension	300 mg/5mL	Novadoz Pharmaceuticals LLC	None
72888-074	OXCARBAZEPINE	suspension	300 mg/5mL	Advagen Pharma Ltd	None
85742-007	Oxcarbazepine	suspension	300 mg/5mL	Kanchan Healthcare Inc	None
31722-687	OXCARBAZEPINE	suspension	60 mg/mL	Camber Pharmaceuticals, Inc.	None
67877-532	Oxcarbazepine	suspension	60 mg/mL	Ascend Laboratories, LLC	None
70377-117	OXCARBAZEPINE	suspension	60 mg/mL	Biocon Pharma Inc.	None
72603-252	OXCARBAZEPINE	suspension	60 mg/mL	NorthStar RxLLC	None
68382-691	oxcarbazepine	tablet	150 mg/1	Zydus Pharmaceuticals (USA) Inc.	None
70771-1842	oxcarbazepine	tablet	150 mg/1	Zydus Lifesciences Limited	None
72888-462	Oxcarbazepine	tablet	150 mg/1	Advagen Pharma Ltd.	None
68382-692	oxcarbazepine	tablet	300 mg/1	Zydus Pharmaceuticals (USA) Inc.	None
70771-1843	oxcarbazepine	tablet	300 mg/1	Zydus Lifesciences Limited	None
72888-460	Oxcarbazepine	tablet	300 mg/1	Advagen Pharma Ltd.	None
68382-693	oxcarbazepine	tablet	600 mg/1	Zydus Pharmaceuticals (USA) Inc.	None
70771-1844	oxcarbazepine	tablet	600 mg/1	Zydus Lifesciences Limited	None
72888-461	Oxcarbazepine	tablet	600 mg/1	Advagen Pharma Ltd.	None
27241-237	Oxcarbazepine	tablet, extended release	150 mg/1	Ajanta Pharma USA Inc.	None
50742-611	Oxcarbazepine	tablet, extended release	150 mg/1	Ingenus Pharmaceuticals, LLC	None
60505-4128	OXCARBAZEPINE	tablet, extended release	150 mg/1	Apotex Corp.	None
27241-238	Oxcarbazepine	tablet, extended release	300 mg/1	Ajanta Pharma USA Inc.	None
50742-612	Oxcarbazepine	tablet, extended release	300 mg/1	Ingenus Pharmaceuticals, LLC	None
60505-4129	OXCARBAZEPINE	tablet, extended release	300 mg/1	Apotex Corp.	None
27241-239	Oxcarbazepine	tablet, extended release	600 mg/1	Ajanta Pharma USA Inc.	None